Fundraising FoxExai Bio Inc.
Palo Alto, US · Founded 2021 · 4 known investors
Find your way into Exai Bio Inc.
Sign up to see every warm intro you have to Exai Bio Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Exai Bio Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ExAI develops technology for early cancer detection, diagnosis, and management. The company serves healthcare providers and patients in the oncology space.
Founders & leadership
PA
Patrick A. ArensdorfExecutive
Board
HG
MP
Michael PelliniBoard director
AP
Alexander ParkerBoard director
Investors · 4
Blue Venture Fundslisted by Blue Venture FundsChicago · $1M – $20M
How we know: Blue Venture Funds's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Amplify PartnersinferredMenlo Park · $500K – $5Mvia Hani Goodarzi · board
How we know: board seat on SEC Form D · Not right? Tell us
S32reportedPalo Alto
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$70.6M disclosed across 1 round · 2021
▶$70.6MraisedOct 2022 · 21 investors · BiotechnologyRule 506(b)
▶$70.6MraisedOct 2022 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander ParkerDirector
- Hani GoodarziDirector
- Michael PelliniDirector
- Patrick A. ArensdorfExecutive Officer, Director
- Offering amount
- $71.5M
- Amount sold
- $70.6M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Exai Bio Inc. do?
- ExAI develops technology for early cancer detection, diagnosis, and management. The company serves healthcare providers and patients in the oncology space.
- Who are Exai Bio Inc.'s investors?
- Exai Bio Inc.'s investors include Blue Venture Funds, Amplify Partners, S32, Sandbox Industries.
- How much funding has Exai Bio Inc. raised?
- Exai Bio Inc. has disclosed $70.6M raised across 1 round.
- Where is Exai Bio Inc. headquartered?
- Exai Bio Inc. is headquartered in Palo Alto, US.